3Johan Groeneveld AB, Beishuizen A, Visser FC. Insulin:a wonder drug in the critically ill? [ J]. Crit Care,2002,6(2) :102 -105.
4Wickeuberg J, Lindstedt S, Berntorp K,et al. Ceylon cinna- mon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance [ J ]. The British Journal of Nutrition, 2012,107(12) : 1845-1849.
5O'Connor E, Tragen D, Fahey P, et al. Improving blood sug- ar control during critical illness: a cohort study[ J].Journal of Critical Care,2010,25( 1 ) :78-83.
6Bagshaw SM, Hoste EA, Jacka M J, et al. Best evidence in critical care medicine. Intensive vs conventional blood glu- cose control in critically ill patients[ J] .Canadian Journal of Anesthesia,2010,57(2) : 172-175.
7Valensi P,Moura I,Magoarou M,et al. Short-term effects of continuoussubcutaneous insulin infusion treatment on insulin secretion in non-in-sulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment [J]. Diabetes Metab,1997,23(1):51-57.
8Finfer S, Chittock DR, Su SY. Intensive versus conventional glucose con- trol in critically ill patients[J]. N Engl J Med, 2009,360( 13 ) :1283 - 1297.
9Kavanagh BP, McCowen KC. Clinical practice:glycemic control in the ICU[J]. N Engl J Med, 2010,363(26) :2540 -2546.
